Innovent Biologics Inc/ADR IVBXF
The SEC does not publish structured financial data (XBRL) for Innovent Biologics Inc/ADR, so there are no statement tables here.
This is common for foreign companies that trade over the counter and for filers that only submit documents.
Its filings are still listed below and on SEC EDGAR.
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| F-6EF | Filing | Aug 8, 2025 | — |
| F-6EF | Form f-6ef | Apr 17, 2019 | — |
Company profile
- Listed as
- IVBXF (OTC)
- Headquarters
- New York, NY
- SEC CIK
- 1774163
Source: SEC EDGAR filings. This is company-reported data, not investment advice.